ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

DVA vs AGL // OPERATING MARGIN

DaVita Inc. (NYSE) VS. agilon health inc. (NYSE) • 15-METRIC TALLY: DVA 8 — AGL 1
▲ OPERATING MARGIN LEADER: DVA
operating-margins
15.00%
operating-margins
-7.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DVA VS. AGL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC DVA AGL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 29.20% -35.00% +64.20 DVA /roic <GO>
EV/EBITDA & P/E Valuation 7.3x — — TIE /valuation <GO>
Free Cash Flow Yield 10.63% -8.25% +18.88 DVA /fcf-yield <GO>
Operating Margin ACTIVE 15.00% -7.80% +22.80 DVA /operating-margins <GO>
Net Profit Margin 7.90% -6.60% +14.50 DVA /net-margins <GO>
Revenue Growth (YoY) 6.50% -2.10% +8.60 DVA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.66 2.06 -0.40 AGL /balance-sheet <GO>
Piotroski F-Score Quality 8/9 3/9 +5.00 DVA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.3 46.4 +12.90 DVA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.95 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 10.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.33B $1.44B $10.89B DVA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR DVA REV AGL REV DVA GROSS % AGL GROSS % DVA FCF AGL FCF
FY 2025 $13.64B $5.93B — — $1.31B -$119.0M
FY 2024 $12.82B $6.06B — — $1.47B -$71.0M
FY 2023 $12.14B $4.32B — — $1.51B -$156.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DVA // BETA 0.95
AGL // BETA —